NCT01547546View on ClinicalTrials.gov

A Study of GDC-0084 in Patients With Progressive or Recurrent High-Grade Glioma

PHASE1CompletedINTERVENTIONAL

Enrollment

29

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions

Glioblastoma, Glioma

Interventions

DRUG

GDC-0084

Multiple doses

Trial Locations (5)

77030

Houston

90095

Los Angeles

02114

Boston

02115

Boston

08035

Barcelona

Sponsors

Lead Sponsor

Genentech, Inc.

All Listed Sponsors

lead

Genentech, Inc.

INDUSTRY

NCT01547546 - A Study of GDC-0084 in Patients With Progressive or Recurrent High-Grade Glioma | Biotech Hunter | Biotech Hunter